Bronconex Acticap

Страна: Нова Зеландия

Език: английски

Източник: Medsafe (Medicines Safety Authority)

Активна съставка:

Mometasone furoate 400ug (anhydrous)

Предлага се от:

Organon (New Zealand) Limited

INN (Международно Name):

Mometasone furoate 400 µg (anhydrous)

дозиране:

400 mcg/dose

Лекарствена форма:

Powder for inhalation

Композиция:

Active: Mometasone furoate 400ug (anhydrous) Excipient: Lactose

Броя в опаковка:

Inhaler, metered, DPI, (sample), 14 dose units

Клас:

Prescription

Вид предписание :

Prescription

Произведено от:

MSD International GmbH (Singapore Branch)

Терапевтични показания:

Bronconex Acticap is indicated for prophylactic therapy in the management of patients with asthma of all severities, including patients who have been dependent upon either inhaled or systemically administered corticosteroids and non-corticosteroid-dependent patients inadequately controlled on other drug regimens.

Каталог на резюме:

Package - Contents - Shelf Life: Inhaler, metered, DPI, (sample) - 14 dose units - 18 months from date of manufacture stored at or below 25°C - Inhaler, metered, DPI - 30 dose units - 18 months from date of manufacture stored at or below 25°C - Inhaler, metered, DPI - 60 dose units - 18 months from date of manufacture stored at or below 25°C

Дата Оторизация:

2000-12-05